The clinical significance of cardiac troponins in medical practice

Journal of the Saudi Heart Association

Volumn 23, Issue 1, 2011, Pages 3-11

  Al Otaiby, Mohammed A ^a   Al Amri, Hussein S ^a   Al Moghairi, Abdulrahman M ^a  

^a Adult Cardiology   (Saudi Arabia)

Author keywords

Cardiac troponin; Myocardial injury; Perioperative infarction; Reinfarction

Indexed keywords

ABCIXIMAB; CREATINE KINASE MB; FIBRINOGEN RECEPTOR ANTAGONIST; LAMIFIBAN; TIROFIBAN; TROPONIN; TROPONIN I; TROPONIN T;

ACUTE CORONARY SYNDROME; ACUTE HEART FAILURE; ACUTE HEART INFARCTION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CRITICALLY ILL PATIENT; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ELECTROCARDIOGRAPHY; FALSE POSITIVE RESULT; HEART; HEART DISEASE; HEART INFARCTION; HEART MUSCLE INJURY; HEART REINFARCTION; HEART SURGERY; HUMAN; INTENSIVE CARE UNIT; KIDNEY FAILURE; LUNG EMBOLISM; MEDICAL PRACTICE; MORTALITY; MYOCARDITIS; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; REVIEW; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURGICAL RISK; TRANSLUMINAL CORONARY ANGIOPLASTY; TRANSTHORACIC ECHOCARDIOGRAPHY; UNSTABLE ANGINA PECTORIS;

EID: 78650023632     PISSN: 10167315     EISSN: 22125043     Source Type: Journal    
DOI: 10.1016/j.jsha.2010.10.001     Document Type: Review

References (82)

1. Abdelmeguid A.E., Topol E.J., Whitlow P.L., Sapp S.K., Ellis S.G. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation 1996, 94(7):1528-1536.
2. Adams J.E., Sicard G.A., Allen B.T., et al. Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. N. Engl. J. Med. 1994, 330(10):670-674.
3. Alpert J.S., Thygesen K., Antman E., Bassand J.P. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J. Am. Coll. Cardiol. 2000, 36(3):959-969.
4. Ammann P., Maggiorini M., Bertel O., et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J. Am. Coll. Cardiol. 2003, 41(11):2004-2009.
5. Anonymous, 1997. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study. Lancet 349 (9063), 1429-1435.
6. Anonymous, 1998. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet receptor inhibition in ischemic syndrome management (PRISM) study investigators. N. Engl. J. Med. 338 (21), 1498-1505.
7. Apple F.S., Murakami M.M. Cardiac troponin and creatine kinase MB monitoring during in-hospital myocardial reinfarction. Clin. Chem. 2005, 51(2):460-463.
8. Apple F.S., Murakami M.M., Pearce L.A., Herzog C.A. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002, 106(23):2941-2945.
9. Bakshi T.K., Choo M.K., Edwards C.C., Scott A.G., Hart H.H., Armstrong G.P. Causes of elevated troponin I with a normal coronary angiogram. Intern Med J 2002, 32(11):520-525.
10. Bassand J.P., Hamm C.W., Ardissino D., et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur. Heart J. 2007, 28(13):1598-1660.
11. Beyne P., Vigier J.P., Bourgoin P., Vidaud M. Comparison of single and repeat centrifugation of blood specimens collected in BD evacuated blood collection tubes containing a clot activator for cardiac troponin I assay on the ACCESS analyzer. Clin. Chem. 2000, 46(11):1869-1870.
12. Bonnefoy E., Filley S., Kirkorian G., et al. Troponin I, troponin T, or creatine kinase-MB to detect perioperative myocardial damage after coronary artery bypass surgery. Chest 1998, 114(2):482-486.
13. Botha P., Nagarajan D.V., Lewis P.S., Dunning J. Can cardiac troponins be used to diagnose a perioperative myocardial infarction post cardiac surgery?. Interact. Cardiovasc. Thorac. Surg. 2004, 3(3):442-449.
14. Braunwald E., Antman E.M., Beasley J.W., et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). J. Am. Coll. Cardiol. 2000, 36(3):970-1062.
15. Cantor W.J., Newby L.K., Christenson R.H., et al. Prognostic significance of elevated troponin I after percutaneous coronary intervention. J. Am. Coll. Cardiol. 2002, 39(11):1738-1744.
16. Carrier M., Pellerin M., Perrault L.P., Solymoss B.C., Pelletier L.C. Troponin levels in patients with myocardial infarction after coronary artery bypass grafting. Ann. Thorac. Surg. 2000, 69(2):435-440.
17. Costa M.A., Carere R.G., Lichtenstein S.V., et al. Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS). Circulation 2001, 104(22):2689-2693.
18. Cunnion R.E., Schaer G.L., Parker M.M., Natanson C., Parrillo J.E. The coronary circulation in human septic shock. Circulation 1986, 73(4):637-644.
19. Dhainaut J.F., Huyghebaert M.F., Monsallier J.F., et al. Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock. Circulation 1987, 75(3):533-541.
20. Dierkes J., Domrose U., Westphal S., et al. Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation 2000, 102(16):1964-1969.
21. Eisenberg M.J., London M.J., Leung J.M., et al. Monitoring for myocardial ischemia during noncardiac surgery. A technology assessment of transesophageal echocardiography and 12-lead electrocardiography. The study of Perioperative Ischemia Research Group. JAMA 1992, 268(2):210-216.
22. Espinoza J., Lipski J., Litwak R., Donoso E., Dack S. New Q waves after coronary artery bypass surgery for angina pectoris. Am. J. Cardiol. 1974, 33(2):221-224.
23. Favory R., Neviere R. Significance and interpretation of elevated troponin in septic patients. Crit. Care 2006, 10(4):224.
24. Force T., Hibberd P., Weeks G., et al. Perioperative myocardial infarction after coronary artery bypass surgery. Clinical significance and approach to risk stratification. Circulation 1990, 82(3):903-912.
25. French J.K., White H.D. Clinical implications of the new definition of myocardial infarction. Heart 2004, 90(1):99-106.
26. Gabr A.E., Ibrahim I.A., Aloulou S.M., Al-Alfi M.A., Al-Abdlrahim K.A. Cardiac troponin T and end stage renal disease. Saudi Med. J. 2004, 25(8):1015-1019.
27. Garbarz E., Iung B., Lefevre G., et al. Frequency and prognostic value of cardiac troponin I elevation after coronary stenting. Am. J. Cardiol. 1999, 84(5):515-518.
28. Goldmann B.U., Christenson R.H., Hamm C.W., Meinertz T., Ohman E.M. Implications of troponin testing in clinical medicine. Curr. Control. Trials Cardiovasc. Med. 2001, 2(2):75-84.
29. Guest T.M., Ramanathan A.V., Tuteur P.G., Schechtman K.B., Ladenson J.H., Jaffe A.S. Myocardial injury in critically ill patients. A frequently unrecognized complication. JAMA 1995, 273(24):1945-1949.
30. Hamm C.W., Ravkilde J., Gerhardt W., et al. The prognostic value of serum troponin T in unstable angina. N. Engl. J. Med. 1992, 327(3):146-150.
31. Harrington R.A., Lincoff A.M., Califf R.M., et al. Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). J. Am. Coll. Cardiol. 1995, 25(7):1693-1699.
32. Hernandez O.M., Housmans P.R., Potter J.D. Invited review: pathophysiology of cardiac muscle contraction and relaxation as a result of alterations in thin filament regulation. J. Appl. Physiol. 2001, 90(3):1125-1136.
33. Horwich T.B., Patel J., MacLellan W.R., Fonarow G.C. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 2003, 108(7):833-838.
34. Jain U. Myocardial infarction during coronary artery bypass surgery. J. Cardiothorac. Vasc. Anesth. 1992, 6(5):612-623.
35. Jeremias A., Gibson C.M. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann. Intern. Med. 2005, 142(9):786-791.
36. Karim M.A., Shinn M.S., Oskarsson H., Windle J., Deligonul U. Significance of cardiac troponin T release after percutaneous transluminal coronary angioplasty. Am. J. Cardiol. 1995, 76(7):521-523.
37. Katus H.A., Remppis A., Looser S., Hallermeier K., Scheffold T., Kubler W. Enzyme linked immuno assay of cardiac troponin T for the detection of acute myocardial infarction in patients. J. Mol. Cell. Cardiol. 1989, 21(12):1349-1353.
38. Katus H.A., Schoeppenthau M., Tanzeem A., et al. Non-invasive assessment of perioperative myocardial cell damage by circulating cardiac troponin T. Br. Heart J. 1991, 65(5):259-264.
39. Keller T., Zeller T., Peetz D., et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N. Engl. J. Med. 2009, 361(9):868-877.
40. King D.A., Codish S., Novack V., Barski L., Almog Y. The role of cardiac troponin I as a prognosticator in critically ill medical patients: a prospective observational cohort study. Crit. Care 2005, 9(4):R390-R395.
41. Kollef M.H., Ladenson J.H., Eisenberg P.R. Clinically recognized cardiac dysfunction: an independent determinant of mortality among critically ill patients. Is there a role for serial measurement of cardiac troponin I?. Chest 1997, 111(5):1340-1347.
42. Korff S., Katus H.A., Giannitsis E. Differential diagnosis of elevated troponins. Heart 2006, 92(7):987-993.
43. La Vecchia L., Bedogni F., Finocchi G., et al. Troponin T, troponin I and creatine kinase-MB mass after elective coronary stenting. Coron. Artery Dis. 1996, 7(7):535-540.
44. Lee T.H., Thomas E.J., Ludwig L.E., et al. Troponin T as a marker for myocardial ischemia in patients undergoing major noncardiac surgery. Am. J. Cardiol. 1996, 77(12):1031-1036.
45. Lehrke S., Steen H., Sievers H.H., et al. Cardiac troponin T for prediction of short- and long-term morbidity and mortality after elective open heart surgery. Clin. Chem. 2004, 50(9):1560-1567.
46. Lim W., Qushmaq I., Devereaux P.J., et al. Elevated cardiac troponin measurements in critically ill patients. Arch. Intern. Med. 2006, 166(22):2446-2454.
47. Lim W., Cook D.J., Griffith L.E., Crowther M.A., Devereaux P.J. Elevated cardiac troponin levels in critically ill patients: prevalence, incidence, and outcomes. Am. J. Crit. Care 2006, 15(3):280-288. quiz 289.
48. Mair J., Artner-Dworzak E., Dienstl A., et al. Early detection of acute myocardial infarction by measurement of mass concentration of creatine kinase-MB. Am. J. Cardiol. 1991, 68(17):1545-1550.
49. Mangano D.T. Perioperative cardiac morbidity. Anesthesiology 1990, 72(1):153-184.
50. McLaurin M.D., Apple F.S., Voss E.M., Herzog C.A., Sharkey S.W. Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: evidence of cardiac troponin T expression in skeletal muscle. Clin. Chem. 1997, 43(6 Pt 1):976-982.
51. Muehlschlegel J.D., Perry T.E., Liu K.Y., et al. Troponin is superior to electrocardiogram and creatinine kinase MB for predicting clinically significant myocardial injury after coronary artery bypass grafting. Eur. Heart J. 2009, 30(13):1574-1583.
52. Neumayr G., Gaenzer H., Pfister R., et al. Plasma levels of cardiac troponin I after prolonged strenuous endurance exercise. Am. J. Cardiol. 2001, 87(3):369-371. A310.
53. Newby L.K., Ohman E.M., Christenson R.H., et al. Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy. Circulation 2001, 103(24):2891-2896.
54. Nienhuis M.B., Ottervanger J.P., Bilo H.J., Dikkeschei B.D., Zijlstra F. Prognostic value of troponin after elective percutaneous coronary intervention: a meta-analysis. Catheter Cardiovasc. Interv. 2008, 71(3):318-324.
55. Okmen E., Cam N., Sanli A., Unal S., Tartan Z., Vural M. Cardiac troponin I increase after successful percutaneous coronary angioplasty: predictors and long-term prognostic value. Angiology 2006, 57(2):161-169.
56. Omland T., de Lemos J.A., Sabatine M.S., et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N. Engl. J. Med. 2009, 361(26):2538-2547.
57. Perna E.R., Macin S.M., Parras J.I., et al. Cardiac troponin T levels are associated with poor short- and long-term prognosis in patients with acute cardiogenic pulmonary edema. Am. Heart J. 2002, 143(5):814-820.
58. Pierpont G.L., McFalls E.O. Interpreting troponin elevations: do we need multiple diagnoses?. Eur. Heart J. 2009, 30(2):135-138.
59. Prasad A., Rihal C.S., Lennon R.J., Singh M., Jaffe A.S., Holmes D.R. Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients. Circ. Cardiovasc. Interv. 2008, 1(1):10-19.
60. Rao S.V., Ohman E.M., Granger C.B., et al. Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes. Am. J. Cardiol. 2003, 91(8):936-940.
61. Ravkilde J., Nissen H., Mickley H., Andersen P.E., Thayssen P., Horder M. Cardiac troponin T and CK-MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris. Am. Heart J. 1994, 127(1):13-20.
62. Righetti A., Crawford M.H., O'Rourke R.A., et al. Detection of perioperative myocardial damage after coronary artery bypass graft surgery. Circulation 1977, 55(1):173-178.
63. Roberts R., Sobel B.E. Editorial: isoenzymes of creatine phosphokinase and diagnosis of myocardial infarction. Ann. Intern. Med. 1973, 79(5):741-743.
64. Roongsritong C., Warraich I., Bradley C. Common causes of troponin elevations in the absence of acute myocardial infarction: incidence and clinical significance. Chest 2004, 125(5):1877-1884.
65. Saadeddin S.M., Habbab M.A., Sobki S.H., Ferns G.A. Minor myocardial injury after elective uncomplicated successful PTCA with or without stenting: detection by cardiac troponins. Cathet. Cardiovasc. Interv. 2001, 53(2):188-192.
66. Sacks D.B. Acute coronary ischemia: troponin I and T. Vasc. Med. 1999, 4(4):253-256.
67. Setsuta K., Seino Y., Takahashi N., et al. Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. Am. J. Cardiol. 1999, 84(5):608-611. A609.
68. Shyu K.G., Kuan P.L., Cheng J.J., Hung C.R. Cardiac troponin T, creatine kinase, and its isoform release after successful percutaneous transluminal coronary angioplasty with or without stenting. Am. Heart J. 1998, 135(5 Pt 1):862-867.
69. Steen H., Giannitsis E., Futterer S., Merten C., Juenger C., Katus H.A. Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function. J. Am. Coll. Cardiol. 2006, 48(11):2192-2194.
70. Swaanenburg J.C., Klaase J.M., DeJongste M.J., Zimmerman K.W., ten Duis H.J. Troponin I, troponin T, CKMB-activity and CKMB-mass as markers for the detection of myocardial contusion in patients who experienced blunt trauma. Clin. Chim. Acta 1998, 272(2):171-181.
71. Swinkels B.M., Sonke G.S., Muller H.P., Peters R.H. Prevalence and clinical significance of an elevated cardiac troponin I in patients presenting to the emergency department without chest pain. Eur. J. Intern. Med. 2006, 17(2):92-95.
72. Testa L., Van Gaal W.J., Biondi Zoccai G.G., et al. Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition. QJM 2009, 102(6):369-378.
73. Thygesen K., Alpert J.S., White H.D., et al. Universal definition of myocardial infarction. Circulation 2007, 116(22):2634-2653.
74. Tung P., Kopelnik A., Banki N., et al. Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke 2004, 35(2):548-551.
75. Tunstall-Pedoe H., Kuulasmaa K., Amouyel P., Arveiler D., Rajakangas A.M., Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994, 90(1):583-612.
76. Udvarhelyi I.S., Gatsonis C., Epstein A.M., Pashos C.L., Newhouse J.P., McNeil B.J. Acute myocardial infarction in the medicare population. Process of care and clinical outcomes. JAMA 1992, 268(18):2530-2536.
77. Uettwiller-Geiger D., Wu A.H., Apple F.S., et al. Multicenter evaluation of an automated assay for troponin I. Clin. Chem. 2002, 48(6 Pt 1):869-876.
78. van Bockel E.A., Tulleken J.E., Muller Kobold A.C., et al. Cardiac troponin I release and cytokine response during experimental human endotoxaemia. Intensive Care Med. 2003, 29(9):1598-1600.
79. Van Lente F., Martin A., Ratliff N.B., Kazmierczak S.C., Loop F.D. The predictive value of serum enzymes for perioperative myocardial infarction after cardiac operations. An autopsy study. J. Thorac. Cardiovasc. Surg. 1989, 98(5 Pt 1):704-710.
80. Van Lente F., McErlean E.S., DeLuca S.A., Peacock W.F., Rao J.S., Nissen S.E. Ability of troponins to predict adverse outcomes in patients with renal insufficiency and suspected acute coronary syndromes: a case-matched study. J. Am. Coll. Cardiol. 1999, 33(2):471-478.
81. Wong G.C., Morrow D.A., Murphy S., et al. Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction. Circulation 2002, 106(2):202-207.
82. Wong P., Murray S., Ramsewak A., Robinson A., van Heyningen C., Rodrigues E. Raised cardiac troponin T levels in patients without acute coronary syndrome. Postgrad. Med. J. 2007, 83(977):200-205.